Not logged inDiscovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Soth, Michael J.; Le, Kang; Di Francesco, Maria Emilia; Hamilton, Matthew M.; Liu, Gang; Burke, Jason P.; Carroll, Chris L.; Kovacs, Jeffrey J.; Bardenhagen, Jennifer P.; Bristow, Christopher A.; Cardozo, Mario; Czako, Barbara; de Stanchina, Elisa; Feng, Ningping; Garvey, Jill R.; Gay, Jason P.; Do, Mary K. Geck; Greer, Jennifer; Han, Michelle; Harris, Angela; Herrera, Zachary; Huang, Sha; Giuliani, Virginia; Jiang, Yongying; Johnson, Sarah B.; Johnson, Troy A.; Kang, Zhijun; Leonard, Paul G.; Liu, Zhen; McAfoos, Timothy; Miller, Meredith; Morlacchi, Pietro; Mullinax, Robert A.; Palmer, Wylie S.; Pang, Jihai; Rogers, Norma; Rudin, Charles M.; Shepard, Hannah E.; Spencer, Nakia D.; Theroff, Jay; Wu, Qi; Xu, Alan; Yau, Ju Anne; Draetta, Giulio; Toniatti, Carlo; Heffernan, Timothy P.; Jones, Philip .png)
Share.png)
SaveA strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybridsZhu, Mingzhao; Harshbarger, Wayne D.; Robles, Omar; Krysiak, Joanna; Hull, Kenneth G.; Cho, Sung Wook; Richardson, Robyn D.; Yang, Yanyan; Garcia, Andres; Spiegelman, Lindsey; Ramirez, Bianca; Wilson, Christopher T.; Yau, Ju Anne; Moore, James T.; Walker, Caitlen B.; Sacchettini, James C.; Liu, Wenshe R.; Sieber, Stephan A.; Smith, Jeffrey W.; Romo, Daniel Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
